Real World Evidence of MammaPrintยฎ and BluePrintยฎ utility for informing axillary surgery decisions in the neoadjuvant setting
Publication: ASBRS 2025 Authors: Thompson et al. Title: Real Read More
High Concordance of 70-Gene Recurrence Risk Signature and 80-Gene Molecular Subtyping Signature Between Core Needle Biopsy and Surgical Resection Specimens in Early-Stage Breast Cancer
Publication: J Surg Oncol. 2022;125:596โ602. Authors: Jennifer A. Crozier Read More
Successful Unconventional Precision Treatment of Inflammatory Hormone Receptor-Positive Breast Cancer Guided by Molecular Profiling
Publication: npj Precision Oncology | (2025) 9:63 Authors: Jailan Read More
Neoadjuvant HER2-Targeted Therapy Response by BluePrint Gene Expression-Based Molecular Subtyping in Patients with HER2+ Early-Stage Breast Cancer from FLEX
Publication: 19th SGBCC 2025-P201 Authors: Laila Samiian, Adam Brufsky, Read More
Genomic risk classification and whole transcriptome analysis of HR+/HER2- Post-partum breast cancers โ A FLEX sub study
Publication: ESMO Breast 2024 Authors:ย Virginia F. Borges1, Elena Shagisultanova1, Read More
Survival Outcomes for Patients With Invasive Lobular Cancer by MammaPrint: Results From the MINDACT Phase III Trial
Publication: European Journal of Cancer 217 (2025) 115222 Authors: Read More
Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision MedicineโBiology Is Still King
Publication: International Journal of Molecular Sciences 2025, 26, 491 Read More
FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients With Early-Stage Breast Cancer
Source: San Antonio Breast Cancer Symposiumยฎ Authors: Robert Maganini, Read More
MammaPrint and BluePrint Predict Pathological Response to Neoadjuvant Chemotherapy in Patients With HR+HER2- Early-Stage Breast Cancer Enrolled in FLEX
Source: San Antonio Breast Cancer Symposiumยฎ Authors: Joyce OโShaughnessy, Read More
Prediction of Chemotherapy Benefit by MammaPrint in HR+HER2- Early Stage Breast Cancer Revealed by the FLEX Registry of Real World Data
Source:ย San Antonio Breast Cancer Symposiumยฎ Authors: Adam Brufsky*, Read More
